NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue451,240161,62615,00019,769
Cost of Revenue57,78929,45435,90033,800
Gross Profit393,451132,172-20,900-14,031
Operating Expenses
Research Development99,92493,62758,39147,691
Selling General and Administrative248,932169,90668,08132,480
Non Recurring----
Others----
Total Operating Expenses406,645292,987162,372113,971
Operating Income or Loss44,595-131,361-147,372-94,202
Income from Continuing Operations
Total Other Income/Expenses Net-22,754-11,1816,2825,273
Earnings Before Interest and Taxes44,595-131,361-147,372-94,202
Interest Expense-30,530-19,523-19,523-19,523
Income Before Tax21,841-142,542-141,090-88,929
Income Tax Expense730---
Minority Interest----
Net Income From Continuing Ops21,111-142,542-141,090-88,929
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income21,111-142,542-141,090-88,929
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares21,111-142,542-141,090-88,929